Memorias do Instituto Oswaldo Cruz

Papers
(The median citation count of Memorias do Instituto Oswaldo Cruz is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Antileishmanial metallodrugs and the elucidation of new drug targets linked to post-translational modifications machinery: pitfalls and progress30
FVB/NJ strain as a mouse model for cutaneous leishmaniasis by Leishmania (L.) amazonensis24
Peeking into the mysterious world of Trypanosoma cruzi and Chagas disease23
Binding of the extracellular matrix laminin-1 to Clostridioides difficile strains20
Genomic surveillance: a potential shortcut for effective Chagas disease management18
Mitochondrial dysfunction on Leishmania (Leishmania) amazonensis induced by ketoconazole: insights into drug mode of action14
An updated gene regulatory network reconstruction of multidrug-resistant Pseudomonas aeruginosa CCBH485114
Translational research in Chagas disease: perspectives in nutritional therapy emerging from selenium supplementation studies as a complementary treatment14
Progressive neuropathy in patients with lepromatous leprosy after multidrug therapy13
Lack of serological and molecular evidences of Zika virus circulation in non-human primates in three states from Brazil12
Unique synapomorphies and high diversity in South American Raji-related Epstein-Barr virus genomes12
First concrete documentation for presence of Aedes (Stegomyia) albopictus in Bolivia: dispelling previous anecdotes11
ERRATUM11
Vitellogenin genes are transcribed in Culex quinquefasciatus ovary10
Matrix-assisted laser desorption/ionisation-time of flight mass spectrometry azole susceptibility assessment in Candida and Aspergillus species10
Leishmania enriettii visceralises in the trachea, lungs, and spleen of Cavia porcellus9
The challenges for targeting Chagas disease for elimination as a public health problem9
Design of a specific peptide against phenolic glycolipid-1 from Mycobacterium leprae and its implications in leprosy bacilli entry9
Electrochemical immunosensor for detection of Plasmodium vivax lactate dehydrogenase8
Population movements, borders, and Chagas disease7
Perspectives for a new drug candidate for Chagas disease therapy7
Histone deacetylase (HDAC) inhibitors- based drugs are effective to control Mycobacterium tuberculosis infection and promote the sensibility for rifampicin in MDR strain6
Sublingual microcirculatory alterations in Chagas disease: an observational study in an endemic rural population6
ERRATUM6
First report of putative Leishmania RNA virus 2 (LRV2) in Leishmania infantum strains from canine and human visceral leishmaniasis cases in the southeast of Brazil5
Multi-therapeutic strategy targeting parasite and inflammation-related alterations to improve prognosis of chronic Chagas cardiomyopathy: a hypothesis-based approach*5
Insecticide resistance levels and associated mechanisms in three Aedes aegypti populations from Venezuela5
Genetic diversity of Trypanosoma cruzi strains isolated from chronic chagasic patients and non-human hosts in the state of São Paulo, Brazil5
Impact of gut-peripheral nervous system axis on the development of diabetic neuropathy5
Trypanosoma cruzi genetic diversity: impact on transmission cycles and Chagas disease5
Emerging and reemerging forms of Trypanosoma cruzi transmission4
Characterization of larval habitats of Anopheles (Nyssorhynchus) darlingi and associated species in malaria areas in western Brazilian Amazon4
Chagas disease challenge - New techniques for diagnosis and treatment address to control in endemic areas4
Revisiting the development of Trypanosoma rangeli in the vertebrate host4
Antileishmanial effects of γCdcPLI, a phospholipase A2 inhibitor from Crotalus durissus collilineatus snake serum, on Leishmania (Leishmania) amazonensis4
Tracing the relationship among HIV-1 sub-subtype F1 strains: a phylodynamic perspective4
Challenges for fighting Chagas disease in the 21st century4
PPE59 antibodies in tuberculous patients and potential use for diagnosis when assayed with other rapid biomarkers4
Rapid on-site detection of echinococcosis and schistosomiasis based on RPA4
Challenges and perspectives in research and teaching of host pathogen interaction topics: new post-pandemic times to Brazil and other South American countries4
Innate immune receptors are differentially expressed in mice during experimental Schistosoma mansoni early infection3
Endocytosis in anaerobic parasitic protists3
Where the DNA hides... In praise of José Rodrigues Coura3
Leptospira interrogans insoluble fraction as a potential antigen source for lateral flow immunochromatography3
First report of Leishmania (Mundinia) martiniquensis in South American territory and confirmation of Leishbunyavirus infecting this parasite in a mare3
Influence of killer immunoglobulin-like receptors genes on the recurrence rate of ocular toxoplasmosis in Brazil3
Molecular mechanisms of action of trypanocidal and leishmanicidal drugs with focus on novel chemotherapeutic strategies: creation of a Brazilian multicentre working group3
Chagas disease and mobility: comments on the challenges for access and the right to health for migrants3
Lipid droplets in Zika neuroinfection: Potential targets for intervention?3
ERRATUM3
Antileishmanial metallodrugs and the elucidation of new drug targets linked to post-translational modifications machinery: pitfalls and progress3
Repositioning drug strategy against Trypanosoma cruzi: lessons learned from HIV aspartyl peptidase inhibitors3
Article-processing charges as a barrier for science in low-to-medium income regions2
Investigating the distribution of a rare Colombo-Venezuelan kissing bug, Rhodnius neivai, Lent, 1953, using geographical information system-based analyses2
Multiplex PCR assays developed for neglected pathogen detection in undifferentiated acute febrile illness cases in tropical regions2
Subregional initiatives for Chagas disease. A path of technical cooperation, opened by the countries, as an approach to a neglected disease2
Memórias do Instituto Oswaldo Cruz celebrates 115 years of scientific publishing: what it needs to keep moving on…2
Heterogeneous persistence of Mycobacterium leprae in oral and nasal mucosa of multibacillary patients during multidrug therapy2
Homozygotes NAT2*5B slow acetylators are highly associated with hepatotoxicity induced by anti-tuberculosis drugs2
Overview of extracellular vesicles in pathogens with special focus on human extracellular protozoan parasites2
Enterovirus infection and its relationship with neurodegenerative diseases2
A straightforward one-step strategy for SARS-CoV-2 diagnosis and screening of variants of concern: a multicentre study2
Improving in vitro screening compounds anti-Trypanosoma cruzi by GFP-expressing parasites2
Giardia lamblia-infected preschoolers present growth delays independent of the assemblage A, B or E2
Chagas disease affects the human placental barrier’s turnover dynamics during pregnancy2
Exploring the performance of Escherichia coli outer membrane vesicles as a tool for vaccine development against Chagas disease2
ERRATUM2
Molecular aspects of Chikungunya virus infections in cancer patients2
Pathophysiology and new targets for therapeutic options in Chagas heart disease1
Molecular detection of omicron SARS-CoV-2 variant is achieved by RT-LAMP despite genomic mutations1
Clinical and epidemiological aspects of Delta and Gamma SARS-CoV-2 variant of concern from the western Brazilian Amazon1
Different profiles of chemokines, cytokines and cell growth factors in plasma samples from patients with leprosy, leprosy reactions and households contacts1
Advances in the development of new vaccines for tuberculosis and Brazil’s role in the effort forward the end TB strategy1
A note on the the discovery of Chagas' disease1
Air in the tires: towards an achievable, efficacious and timely diagnosis for Chagas disease1
The risk of vector transmission of Trypanosoma cruzi remains high in the State of Paraná1
Differential expression of peptidases in Strigomonas culicis wild-type and aposymbiotic strains: from proteomic data to proteolytic activity1
First case of Oropouche fever detected in the international border region of the Colombian Amazon: clinical characteristics and molecular diagnosis1
Coagulopathy and the humoral response against viral proteins in patients at different stages of COVID-191
Clinically silent Plasmodium vivax infections in native Amazonians of northwestern Brazil: acquired immunity or low parasite virulence?1
Reflections on Chagas disease in the Amazon1
The scientific publication of the Memórias do Instituto Oswaldo Cruz (1909-2020): a history of contribution to the biomedical sciences1
Irrigation, migration and infestation: a case study of Chagas disease vectors and bed bugs in El Pedregal, Peru1
Differences in responses to the intracellular macrophage environment between Mycobacterium bovis BCG vaccine strains Moreau and Pasteur1
Predictors of Trypanosoma cruzi PCR positivity in patients with chronic Chagas disease1
Mapping Yellow fever epidemics as a potential indicator of the historical range of Aedes aegypti in the United States1
Assessment of immune responses to a Comirnaty® booster following CoronaVac® vaccination in healthcare workers1
Prevalence and force of Plasmodium vivax blood-stage infection and associated clinical malaria burden in the Brazilian Amazon1
The multidimensional comprehension of Chagas disease. Contributions, approaches, challenges and opportunities from and beyond the Information, Education and Communication field1
Increased angiogenesis parallels cardiac tissue remodelling in experimental acute Trypanosoma cruzi infection1
The translational challenge in Chagas disease drug development1
Revisiting Chagas' disease diagnostic strategies in light of different scenarios of Trypanosoma cruzi infection1
Parasitological, serological and molecular diagnosis of acute and chronic Chagas disease: from field to laboratory1
Unveiling the genome of a high-risk pandrug-resistant Klebsiella pneumoniae emerging in the Brazilian Amazon Region, 20221
How people affected by Chagas disease have struggled with their negligence: history, associative movement and World Chagas Disease Day1
Leishmania (Sauroleishmania) tarentolae versus pathogenic species: comparative evaluation of protease activity, glycoconjugates, resistance to complement and metabolome composition1
HIV-1 controllers exhibit an enhanced antiretroviral innate state characterised by overexpression of p21 and MCPIP1 and silencing of ERVK-6 RNA expression1
Chikungunya virus infection in the southernmost state of Brazil was characterised by self-limited transmission (2017-2019) and a larger 2021 outbreak1
New possibilities for chromoblastomycosis and phaeohyphomycosis treatment: identification of two compounds from the MMV Pathogen Box® that present synergism with itraconazole1
Reflections, suggestions for putting into practice the principles of information, education and communication - IEC on Chagas disease in a community context1
Animal models and SARS-CoV-2-induced pulmonary and neurological injuries1
Chagas disease and its historicity1
Fast surveillance response reveals the introduction of a new yellow fever virus sub-lineage in 2021, in Minas Gerais, Brazil1
In vitro susceptibility of eighteen clinical isolates of human monkeypox virus to tecovirimat1
A glimmer of hope for a neglected disease - How Chagas disease associative movement is driving progress towards disease control and elimination1
Plants of the family Lamiaceae as a source of therapeutic agents against Acanthamoeba infections1
CCR6 expression reduces mouse survival upon malarial challenge with Plasmodium berghei NK65 strain1
Climate change-induced degradation of expert range maps drawn for kissing bugs (Hemiptera: Reduviidae) and long-standing current and future sampling gaps across the Americas1
Leishmania spp. genetic factors associated with cutaneous leishmaniasis antimony pentavalent drug resistance: a systematic review1
Why do we still have not a vaccine against Chagas disease?1
The present and future research agenda of sporotrichosis on the silver anniversary of zoonotic sporotrichosis in Rio de Janeiro, Brazil1
0.063334941864014